然而CAR T疗法针对胶质母细胞瘤（Glioblastoma，GBM）在内的诸多实体瘤效果却十分有限。为了进一步提升CAR T细胞在治疗实体瘤时的疗效，当前大多数研究致力于改良CAR ...

以上研究揭示了同种异体干细胞移植后发生免疫排斥的表观调控新机制。不仅如此，通过生物信息学分析，该机制和靶点也广泛存在于其他种属和其他类型的细胞中。该通用型细胞构建策略的优势在于： ...

The following is a summary of “Role of dormancy survival regulator and resuscitation-promoting factors antigens in ...

流感疫苗比你想的可有用太多了,流感,疫苗,病毒,流行性感冒,活疫苗,接种 ...

As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...

Even treated with the most advanced therapies, patients with glioblastoma—an aggressive brain cancer—typically survive less ...

In a recent study published in the journal Frontiers in Immunology, researchers investigate the impact of dietary antigens in ...

Therapeutics reports preclinical data showing strong anti-cancer activity of its next generation, personalized, off-the-shelf, ...

Australia is ramping up its defences against foot-and-mouth disease, after tapping a pharmaceutical company to provide ...

A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during the SITC annual meeting.